| Financial Year |
March 31 2023 |
| Monetary Funds |
349,444,459.50 |
| Held-for-trading Financial Assets |
180,745,537.92 |
| Notes Receivable |
527,957,100.76 |
| Accounts Receivable |
326,317,830.53 |
| Advances to Suppliers |
91,252,861.59 |
| Other Receivables |
25,969,323.35 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
416,756,888.94 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
58,030,307.86 |
| Total Current Assets |
2,226,595,305.97 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
437,888,380.75 |
| Investment Properties |
-- |
| Fixed Assetes |
1,754,658,773.19 |
| Under-construction Projects |
261,243,493.82 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
432,327,523.30 |
| R&D expenses |
-- |
| Goodwill |
74,855,535.59 |
| Long-Term Deferred and Prepaid Expenses |
356,053,574.46 |
| Deferred Income Tax Assets |
55,499,814.60 |
| Other Non-Current Assets |
305,414,683.88 |
| Sub-Total of Non-Current Assets |
3,689,830,371.95 |
| Total Assets |
5,916,425,677.92 |
| Short-Term Loans |
1,315,817,580.47 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
246,651,440.35 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
24,502,806.50 |
| Taxes Payable |
15,948,861.67 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
98,930,254.78 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
59,354,638.69 |
| Other Current Liabilities |
414,971,222.60 |
| Sub-Total of Current Liabilities |
2,264,002,690.44 |
| Long-term Loans |
140,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
12,961,356.53 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
213,254,103.62 |
| Total Liabilities |
2,477,256,794.06 |
| Paid-In Capital(Or Share Stock) |
680,098,200.00 |
| Capital Surplus |
1,653,075,827.13 |
| Surplus Reserve |
203,428,356.83 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
574,499,000.19 |
| Minority Stockholder's Interest |
251,496,420.39 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,187,672,463.47 |
| Owner's Equity（Stockholder's Equity） |
3,439,168,883.86 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,916,425,677.92 |
